Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 675,040 | 482,375 | 401,858 | 365,978 | 353,874 |
| Cost of Goods | 10,882 | 6,481 | 5,385 | 5,281 | 5,582 |
| Gross Profit | 664,158 | 475,894 | 396,473 | 360,697 | 348,292 |
| Operating Expenses | 528,089 | 369,093 | 284,224 | 236,501 | 220,672 |
| Operating Income | 136,951 | 107,282 | 112,634 | 124,477 | 128,202 |
| Other Income | 24,542 | 17,275 | 3,557 | 529 | 3,400 |
| Pre-tax Income | 161,493 | 124,557 | 116,191 | 125,006 | 131,602 |
| Income Tax | 20,284 | 18,417 | 14,773 | 12,494 | 25,591 |
| Net Income Continuous | 141,209 | 106,140 | 101,418 | 112,512 | 106,011 |
| Net Income | $141,209 | $106,140 | $101,418 | $112,512 | $106,011 |
| EPS Basic Total Ops | 1.35 | 1.02 | 0.95 | 0.97 | 0.92 |
| EPS Basic Continuous Ops | 1.37 | 1.02 | 0.95 | 0.97 | 0.92 |
| EPS Diluted Total Ops | 1.23 | 0.94 | 0.87 | 0.89 | 0.85 |
| EPS Diluted Continuous Ops | 1.24 | 0.95 | 0.87 | 0.89 | 0.85 |
| EPS Diluted Before Non-Recurring Items | 1.23 | 0.94 | 0.87 | 0.89 | 0.85 |
| EBITDA(a) | $127,349 | $100,516 | $117,463 | $133,036 | $130,439 |